BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21098452)

  • 1. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study.
    Saxon LA; Hayes DL; Gilliam FR; Heidenreich PA; Day J; Seth M; Meyer TE; Jones PW; Boehmer JP
    Circulation; 2010 Dec; 122(23):2359-67. PubMed ID: 21098452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of patients with implantable cardioverter defibrillators in the era of remote-monitoring: the 5000-foot, high-altitude view.
    Lampert R
    Circulation; 2010 Dec; 122(23):2353-5. PubMed ID: 21098454
    [No Abstract]   [Full Text] [Related]  

  • 3. The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients.
    Varma N; Piccini JP; Snell J; Fischer A; Dalal N; Mittal S
    J Am Coll Cardiol; 2015 Jun; 65(24):2601-2610. PubMed ID: 25983008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry.
    Cheng A; Wang Y; Curtis JP; Varosy PD
    J Am Coll Cardiol; 2010 Nov; 56(20):1651-6. PubMed ID: 21050975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database.
    Landolina M; Gasparini M; Lunati M; Iacopino S; Boriani G; Bonanno C; Vado A; Proclemer A; Capucci A; Zucchiatti C; Valsecchi S; Ricci RP; Santini M;
    Circulation; 2011 Jun; 123(22):2526-35. PubMed ID: 21576653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.
    Auricchio A; Metra M; Gasparini M; Lamp B; Klersy C; Curnis A; Fantoni C; Gronda E; Vogt J;
    Am J Cardiol; 2007 Jan; 99(2):232-8. PubMed ID: 17223424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of atrial fibrillation on early complications and one year-survival after cardioverter defibrillator implantation: results from the German DEVICE registry.
    Köbe J; Wasmer K; Andresen D; Kleemann T; Spitzer SG; Jehle J; Brachmann J; Stellbrink C; Hochadel M; Senges J; Klein HU; Eckardt L
    Int J Cardiol; 2013 Oct; 168(4):4184-90. PubMed ID: 23948108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II.
    Goldenberg I; Gillespie J; Moss AJ; Hall WJ; Klein H; McNitt S; Brown MW; Cygankiewicz I; Zareba W;
    Circulation; 2010 Sep; 122(13):1265-71. PubMed ID: 20837894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
    Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
    Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
    van der Heijden AC; Borleffs CJ; Buiten MS; Thijssen J; van Rees JB; Cannegieter SC; Schalij MJ; van Erven L
    Heart Rhythm; 2015 Jun; 12(6):1169-76. PubMed ID: 25749138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of appropriate defibrillator therapy among patients with an implantable defibrillator that delivers cardiac resynchronization therapy.
    Desai AD; Burke MC; Hong TE; Kim S; Salem Y; Yong PG; Knight BP
    J Cardiovasc Electrophysiol; 2006 May; 17(5):486-90. PubMed ID: 16684019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.
    Borleffs CJ; van Rees JB; van Welsenes GH; van der Velde ET; van Erven L; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2010 Mar; 55(9):879-85. PubMed ID: 20185038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.
    Ypenburg C; van Erven L; Bleeker GB; Bax JJ; Bootsma M; Wijffels MC; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2006 Aug; 48(3):464-70. PubMed ID: 16875970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interlead difference between T-peak to T-end intervals in resynchronization patients with an implantable cardioverter-defibrillator.
    Suzuki A; Shiga T; Nakai K; Futagawa K; Matsuyama Y; Shoda M; Kasanuki H; Hagiwara N
    J Electrocardiol; 2010; 43(6):706-12. PubMed ID: 20719332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term retention of cardiac resynchronization therapy.
    Knight BP; Desai A; Coman J; Faddis M; Yong P
    J Am Coll Cardiol; 2004 Jul; 44(1):72-7. PubMed ID: 15234410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Zaman S; Sivagangabalan G; Narayan A; Thiagalingam A; Ross DL; Kovoor P
    Circulation; 2009 Jul; 120(3):194-200. PubMed ID: 19581496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
    Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
    J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardiac device procedures in older patients: use and in-hospital outcomes.
    Swindle JP; Rich MW; McCann P; Burroughs TE; Hauptman PJ
    Arch Intern Med; 2010 Apr; 170(7):631-7. PubMed ID: 20386008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.